AX-2025-020384
MGF · 5 mg declared · Xi'an Mokemei Biotechnology Co., Ltd. · lot MKM-2508-S3601
- Report ID
- AX-2025-020384
- Compound
- MGF
- Compound class
- Growth-hormone axis peptides
- Supplier
- MKM — Xi'an Mokemei Biotechnology Co., Ltd.
- Batch / lot
- MKM-2508-S3601
- Declared label claim
- 5mg
- Laboratory
- Medutest
- Assay date
- 02 Sep 2025
- Submitted
- 25 Sep 2025
- Quarter
- 2025-Q3
- Submitter
- f.vukovic
- Sample provenance
- Supplier-supplied
Results
Measured against the index acceptance specification for the growth-hormone axis peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.
| Parameter | Method | Result | Unit | Index spec | |
|---|---|---|---|---|---|
| Purity | RP-HPLC, 25 min gradient, 214 nm | 98.30 | % area | ≥ 97.5 | PASS |
| Total impurities | RP-HPLC, sum of reported peaks | 1.70 | % area | ≤ 2.5 | PASS |
| Largest single impurity | RP-HPLC — acetyl adduct (+42 Da) | 0.71 | % area | ≤ 1.00 | PASS |
| Identity — theoretical monoisotopic mass | calculated from molecular formula | 2886.5117 | Da | — | NOT TESTED |
| Identity — observed monoisotopic mass | LC-MS, unit resolution (single quadrupole) | 2886.4300 | Da | — | NOT TESTED |
| Mass accuracy | observed vs theoretical | -28.3 | ppm | ± 15 | FAIL |
| Total peptide content | by difference from the gravimetric mass balance | 89.77 | %w/w | — | NOT TESTED |
| Target-compound content | total peptide content × purity | 88.24 | %w/w | — | NOT TESTED |
| Gross fill (as weighed) | five-place balance, under nitrogen | 5.21 | mg | 5 mg declared | NOT TESTED |
| Recovered target peptide | gross fill × target content | 4.597 | mg | 5 mg claim | NOT TESTED |
| Recovery against label claim | recovered ÷ claim | 91.9 | % | 90.0 – 110.0 | PASS |
| Water content | Karl Fischer, coulometric, duplicate | 3.25 | % | ≤ 9.0 | PASS |
| Counter-ion (acetate) | anion-exchange ion chromatography | 6.37 | % | ≤ 12.0 | PASS |
| Residual solvent + inorganic residue | estimated — see /methods/residual-solvents-q3c/ | 0.61 | % | — | NOT TESTED |
| Endotoxin | kinetic chromogenic LAL | 0.75 | EU/mg | ≤ 5.0 | PASS |
| Sterility | membrane filtration, USP <71>, 14 d | No growth at 14 d | — | no growth | PASS |
| Appearance | visual, diffuse light, black and white background | White lyophilised cake, intact | — | white to off-white intact cake | PASS |
| Reconstitution clarity | reconstituted per submitter procedure | Clear, colourless, no visible particulates | — | clear, no visible particulates | PASS |
| pH (reconstituted, 1 mg/mL) | potentiometric, two-point calibration | 5.12 | — | 2.5 – 8.0 | PASS |
| Retention time (observed) | RP-HPLC, 25 min gradient | 9.92 | min | 9.84 ± 0.30 (normalised) | PASS |
| Peak asymmetry (10 % height) | Ph. Eur. 2.2.46 | 1.03 | — | 0.80 – 1.50 | PASS |
| Plate count, main peak | N = 5.54 (t/w½)² | 86,251 | — | ≥ 20,000 | PASS |
| Resolution to nearest impurity | vs deamidated (+1 Da) | 1.44 | — | no index criterion | REPORTED |
Chromatogram and peak integration
The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.
| # | Peak | RT | Area (µV·s) | % area | Δ mass (Da) |
|---|---|---|---|---|---|
| 1 | MGF — main peak | 9.92 | 4,777,685 | 98.30 | — |
| 2 | acetyl adduct (+42 Da) | 10.25 | 34,508 | 0.71 | +42.011 |
| 3 | deamidated (+1 Da) | 9.72 | 31,592 | 0.65 | +0.984 |
| 4 | aspartimide (−18 Da) | 10.19 | 9,235 | 0.19 | -18.011 |
| 5 | truncated (1-20) | 8.90 | 7,290 | 0.15 | -486.271 |
| Closure check — purity + Σ impurities | 100.00 | CLOSES | |||
Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.
Mass spectrum and identity
Theoretical monoisotopic mass 2886.5117 Da, computed from C121H200N42O37. All ppm figures on this site are against monoisotopic values — see why that matters.
| Charge | Theoretical m/z | Observed m/z | Δ m/z | Rel. abundance (%) |
|---|---|---|---|---|
| 5+ | 578.3096 | 578.2933 | -0.0163 | 8.8 |
| 4+ | 722.6352 | 722.6148 | -0.0204 | 54.1 |
| 3+ | 963.1778 | 963.1506 | -0.0272 | 100.0 |
| 2+ | 1444.2631 | 1444.2223 | -0.0408 | 49.5 |
Gravimetric mass balance
Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.
| Component | Determination | %w/w of cake |
|---|---|---|
| Water | Karl Fischer | 3.25 |
| Counter-ion (acetate) | ion chromatography | 6.37 |
| Residual solvent + inorganic residue | estimated | 0.61 |
| Total peptide content | by difference | 89.77 |
| Total | 100.00 CLOSES | |
Supplier certificate, as declared
The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.
| Figure | Supplier COA | This report | Index note |
|---|---|---|---|
| Purity (% area) | 98.27 | 98.30 | divergence -0.03 pp vs batch median |
| Total impurities (% area) | 1.73 | 1.70 | |
| Largest single impurity (% area) | 0.61 | 0.71 | |
| Water (%) | not stated | 3.25 | |
| Counter-ion (%) | not stated | 6.37 | |
| Peptide content (%w/w) | not stated | 89.77 | |
| Endotoxin (EU/mg) | 0.63 | 0.75 | |
| Method stated on certificate | YES | — | column, gradient and wavelength given |
Provenance and caveats
Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.
- Sample provenance
- Supplier-supplied
- Evidentiary weight
- Weaker evidence. Read with the caveat below.
- Chain of custody
- Supplier despatch → laboratory direct (courier, cold pack, 2 d) → assay. Submitter did not handle the vial.
- Assay date
- 02 Sep 2025
- Submitted to the index
- 25 Sep 2025
- Laboratory
- Medutest, Ljubljana, Slovenia
- Method basis
- 25 min gradient · unit-resolution MS
- Verification status
- IDENTITY CONSISTENT
Annotations
No annotations on this record. Annotations are short signed technical comments from index contributors; see how to contribute.
Related records
Same batch — lot MKM-2508-S3601 n=3
| Report | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020385 | MKM-2508-S3601 | Janoshik | 2025-Q3 | 98.50 | 3.67 | 98.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020386 | MKM-2508-S3601 | Janoshik | 2025-Q3 | 98.20 | 3.50 | — | Supplier-supplied | 1 | MARGINAL |
Cross-sections
- All MGF records n=32
- All MKM records n=272
- All Medutest records n=940
- All 2025-Q3 records n=819
- MGF by supplier
- MGF impurity profile
| Report | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043516 | BCH | BCH-2511-D7240 | PeptideMeter | 2026-Q2 | 99.03 | 5.80 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043515 | BCH | BCH-2511-D7240 | Janoshik | 2026-Q2 | 98.77 | 4.95 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043514 | BCH | BCH-2511-D7240 | Nordanalyt | 2026-Q2 | 99.17 | 5.89 | 97.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043517 | BCH | BCH-2511-D7240 | PeptideMeter | 2026-Q2 | 98.66 | 5.59 | 102.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043520 | BCH | BCH-2511-D7240 | Janoshik | 2026-Q2 | 98.90 | 5.81 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043512 | BCH | BCH-2511-D7240 | Kestrel | 2026-Q2 | 99.04 | 5.56 | 103.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043511 | BCH | BCH-2511-D7240 | Janoshik | 2026-Q2 | 98.69 | 6.01 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043513 | BCH | BCH-2511-D7240 | Kestrel | 2026-Q2 | 98.48 | 5.77 | 99.6 | Buyer-sourced | 0 | PASS |
| Report | Compound | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042943 | Adipotide | MKM-2606-K4013 | Janoshik | 2026-Q3 | 97.92 | 6.31 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042891 | CJC-1295 (no DAC) | MKM-2603-V2347 | Janoshik | 2026-Q3 | 99.28 | 3.63 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042942 | Adipotide | MKM-2606-K4013 | VendorInvestigate | 2026-Q3 | 97.04 | 5.56 | 94.6 | Buyer-sourced | 1 | FAIL |
| AX-2026-042914 | Gonadorelin | MKM-2604-A2596 | Janoshik | 2026-Q2 | 99.93 | 5.19 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042884 | BPC-157 | MKM-2605-X2575 | Nordanalyt | 2026-Q2 | 98.12 | 2.89 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-042946 | Tirzepatide | MKM-2601-L3752 | Medutest | 2026-Q2 | 97.71 | 8.10 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042911 | Gonadorelin | MKM-2604-A2596 | Medutest | 2026-Q2 | 99.08 | 5.55 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042932 | L-Glutathione (reduced) | MKM-2511-F2902 | Janoshik | 2026-Q2 | 98.57 | 8.41 | 92.9 | Supplier-supplied | 1 | MARGINAL |